These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36684929)

  • 1. Comparison of vaccine hesitancy during the low and high points of COVID-19 in a population under international sanctions: A longitudinal mixed-methods study in Iran.
    Khankeh H; Pourebrahimi M; Hosseinabadi-Farahani M; Farrokhi M; Khanjani MS; Shojafard J; Hamedanchi A; Ranjbar M; Jenabi Ghods M; Ahmadi S; Ghanaatpisheh E; Saatchi M
    Front Public Health; 2022; 10():958899. PubMed ID: 36684929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Barriers, Challenges, and Strategies of COVID-19 (SARS-CoV-2) Vaccine Acceptance: A Concurrent Mixed-Method Study in Tehran City, Iran.
    Khankeh HR; Farrokhi M; Khanjani MS; Momtaz YA; Forouzan AS; Norouzi M; Ahmadi S; Harouni GG; Roudini J; Ghanaatpisheh E; Hamedanchi A; Pourebrahimi M; Alipour F; Ranjbar M; Naghikhani M; Saatchi M
    Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motivators and Demotivators for COVID-19 Vaccination Based on Co-Occurrence Networks of Verbal Reasons for Vaccination Acceptance and Resistance: Repetitive Cross-Sectional Surveys and Network Analysis.
    Liao Q; Yuan J; Wong IOL; Ni MY; Cowling BJ; Lam WWT
    JMIR Public Health Surveill; 2024 Apr; 10():e50958. PubMed ID: 38648099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross sectional study to examine factors influencing COVID-19 vaccine acceptance, hesitancy and refusal in urban and rural settings in Tamil Nadu, India.
    Joshi A; Surapaneni KM; Kaur M; Bhatt A; Nash D; El-Mohandes A
    PLoS One; 2022; 17(6):e0269299. PubMed ID: 35679313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions and Concerns Regarding COVID-19 Vaccination in a Military Base Population.
    Theis SR; Li PC; Kelly D; Ocampo T; Berglund A; Morgan D; Markert R; Fisher E; Burtson K
    Mil Med; 2022 Oct; 187(11-12):e1255-e1260. PubMed ID: 34117501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptance of COVID-19 vaccine and determinant factors in the Iranian population: a web-based study.
    Omidvar S; Firouzbakht M
    BMC Health Serv Res; 2022 May; 22(1):652. PubMed ID: 35578251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
    Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
    JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries.
    Marzo RR; Ahmad A; Islam MS; Essar MY; Heidler P; King I; Thiyagarajan A; Jermsittiparsert K; Songwathana K; Younus DA; El-Abasiri RA; Bicer BK; Pham NT; Respati T; Fitriyana S; Faller EM; Baldonado AM; Billah MA; Aung Y; Hassan SM; Asad MM; El-Fass KA; Bhattacharya S; Shrestha S; Hamza NAE; Friedmann P; Head M; Lin Y; Yi S
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010103. PubMed ID: 35089917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand.
    Sirikalyanpaiboon M; Ousirimaneechai K; Phannajit J; Pitisuttithum P; Jantarabenjakul W; Chaiteerakij R; Paitoonpong L
    BMC Infect Dis; 2021 Nov; 21(1):1174. PubMed ID: 34809607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana.
    Tlale LB; Gabaitiri L; Totolo LK; Smith G; Puswane-Katse O; Ramonna E; Mothowaeng B; Tlhakanelo J; Masupe T; Rankgoane-Pono G; Irige J; Mafa F; Kolane S
    PLoS One; 2022; 17(2):e0263375. PubMed ID: 35120163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey.
    Hong J; Xu XW; Yang J; Zheng J; Dai SM; Zhou J; Zhang QM; Ruan Y; Ling CQ
    J Integr Med; 2022 Jan; 20(1):34-44. PubMed ID: 34774463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An empirical assessment of the factors influencing acceptance of COVID-19 vaccine uptake between Kenyan and Hungarian residing populations: A cross-sectional study.
    Macharia JM; Gakenye GW; Rozmann N; Onchonga D; Mwangi RW; Kaposztas Z; Mathenge JM; Pusztai D; Pinter M; Sugar M; Raposa BL
    Sci Rep; 2022 Dec; 12(1):22262. PubMed ID: 36564451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
    Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
    Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic predictors of COVID-19 vaccine hesitancy and leading concerns with COVID-19 vaccines among pregnant women at a South Texas clinic.
    Sutanto MY; Hosek MG; Stumpff SK; Neuhoff BK; Hernandez BS; Wang Z; Ramsey PS; Boyd AR
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10368-10374. PubMed ID: 36195447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake.
    Moradpour J; Shajarizadeh A; Carter J; Chit A; Grootendorst P
    PLoS One; 2023; 18(11):e0293184. PubMed ID: 37917650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccine hesitancy: assessing the prevalence, predictors, and effectiveness of a community pharmacy based counseling intervention.
    Kiptoo J; Isiiko J; Yadesa TM; Rhodah T; Alele PE; Mulogo EM
    BMC Public Health; 2024 Jan; 24(1):111. PubMed ID: 38184570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccine Hesitancy Among Patients With Epilepsy or Other Chronic Conditions.
    Asadi-Pooya AA; Barzegar Z; Sadeghian S; Nezafat A; Shahisavandi M; Nabavizadeh SA
    Disaster Med Public Health Prep; 2022 Oct; 16(5):1848-1850. PubMed ID: 34629142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct and Indirect Associations of Media Use With COVID-19 Vaccine Hesitancy in South Korea: Cross-sectional Web-Based Survey.
    Lee M; You M
    J Med Internet Res; 2022 Jan; 24(1):e32329. PubMed ID: 34870605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.